Exam 18: Epidemiologic Approach to Evaluating Screening Programs
Exam 1: Introduction4 Questions
Exam 2: The Dynamics of Disease Transmission11 Questions
Exam 3: The Occurrence of Disease: Idisease Surveillance and Measures of Morbidity7 Questions
Exam 4: The Occurrence of Disease: II. Mortality and Other Measures of Disease Impact12 Questions
Exam 5: Assessing the Validity and Reliability of Diagnostic and Screening Tests14 Questions
Exam 6: The Natural History of Disease: Ways of Expressing Prognosis7 Questions
Exam 7: Observational Studies12 Questions
Exam 8: Cohort Studies7 Questions
Exam 10: Assessing Preventive and Therapeutic Measures: Randomized Trials4 Questions
Exam 11: Randomized Trials: Some Further Issues2 Questions
Exam 12: Estimating Risk: Is There an Association12 Questions
Exam 13: More on Risk: Estimating the Potential for Prevention9 Questions
Exam 14: From Association to Causation: Deriving Inferences From Epidemiologic Studies6 Questions
Exam 15: More on Causal Inference: Bias, Confounding, and Interaction10 Questions
Exam 16: Identifying the Roles of Genetic and Environmental Factors in Disease Causation6 Questions
Exam 17: Using Epidemiology to Evaluate Health Services7 Questions
Exam 18: Epidemiologic Approach to Evaluating Screening Programs12 Questions
Exam 19: Epidemiology and Public Policy4 Questions
Exam 20: Ethical and Professional Issues in Epidemiology4 Questions
Select questions type
Epidemiologists decided to investigate the validity of new diagnostic tool for breast cancer.They used this new diagnostic tool for breast cancer in 150 women with biopsy-proven breast cancer in 300 age- and race-matched control women.The results of the new tool were positive in 136 cases and in 35 control women,all of whom showed no evidence of cancer at biopsy.Now,the epidemiologists want to use the new diagnostic tool for screening program in Cities A and B.Based on previous cross-sectional studies,the prevalence of breast cancer is 5% in City A and 1% in City B.What is the expected positive predictive value of new diagnosis tool for breast cancer in City A?
Free
(Multiple Choice)
4.9/5
(35)
Correct Answer:
A
Which of the following statements is the most accurate example of tertiary prevention?
Free
(Multiple Choice)
4.9/5
(44)
Correct Answer:
E
Which of the following statements is the most accurate example of secondary prevention?
Free
(Multiple Choice)
4.8/5
(38)
Correct Answer:
C
Which of the following statements is not an accurate description of epidemiologic studies using large group data such as National Hospital Discharge Survey or National Health Interview Survey?
(Multiple Choice)
4.9/5
(36)
In the model of the Natural History of Disease,the period of time between the onset of signs and symptoms of disease and its ultimate outcome (cure,control,or death) is known as
(Multiple Choice)
4.9/5
(40)
Which of the following statements is the most accurate example of primary prevention?
(Multiple Choice)
4.9/5
(31)
The usual time to death after diagnosis of disease X is 2 years.A screening program allows for the early detection of disease X,on average 1 year earlier than the usual diagnosis; however,there is no available treatment even in early stages of disease X.With the screening program it seems like the time to death has increased to 3 years; however,this is only due to the early diagnosis thanks to the screening program.What is the name of the issue previously described?
(Multiple Choice)
4.9/5
(42)
The following is a reason for an apparent lack of benefit from a screening program:
(Multiple Choice)
4.8/5
(41)
In the model of the Natural History of Disease,when is the ideal time to do screening for a disease?
(Multiple Choice)
4.9/5
(33)
Epidemiologists decided to investigate the validity of new diagnostic tool for breast cancer.They used this new diagnostic tool for breast cancer in 150 women with biopsy-proven breast cancer in 300 age- and race-matched control women.The results of the new tool were positive in 136 cases and in 35 control women,all of whom showed no evidence of cancer at biopsy.What is the sensitivity of new diagnosis tool for breast cancer?
(Multiple Choice)
4.8/5
(40)
Epidemiologists decided to investigate the validity of new diagnostic tool for breast cancer.They used this new diagnostic tool for breast cancer in 150 women with biopsy-proven breast cancer in 300 age- and race-matched control women.The results of the new tool were positive in 136 cases and in 35 control women,all of whom showed no evidence of cancer at biopsy.Now,the epidemiologists want to use the new diagnostic tool for screening program in Cities A and B.Based on previous cross-sectional studies,the prevalence of breast cancer is 5% in City A and 1% in City B.What is the most reasonable conclusion to be drawn from these data?
(Multiple Choice)
4.8/5
(35)
A recent study found that screening for disease X led to increased survival.In the study,those who were screened were generally younger,healthier,and more aware of their health than those who were not screened.This makes it hard to evaluate whether the improvement in survivorship was due to the screening program or due to the characteristics of those who are screened.What is the name of this issue when evaluating the effect of a screening program?
(Multiple Choice)
4.8/5
(36)
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)